sacituzumab
gilead sciences
['breast', 'trodelvy', 'gilead']
 results presented at #esmo2022 indicate superior overall survival with #trodelvy over physician s choice therapy #hr+ #her2- metastatic #breastcancer #visualabstract 
A medical communication agency, we help pharmaceutical companies and healthcare professionals explain their scientific content to the target audience.